BSE Live
Apr 21, 14:56Prev. Close
2327.95
Open Price
2315.00
Bid Price (Qty.)
2250.15 (5)
Offer Price (Qty.)
2264.60 (4)
NSE Live
Apr 21, 14:56Prev. Close
2299.30
Open Price
2325.00
Bid Price (Qty.)
2256.10 (2)
Offer Price (Qty.)
2265.40 (1)
| Balance Sheet of NGL Fine Chem (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 | |
| Total Share Capital | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 | |
| Reserves and Surplus | 279.35 | 259.54 | 219.46 | 200.13 | 151.37 | |
| Total Reserves and Surplus | 279.35 | 259.54 | 219.46 | 200.13 | 151.37 | |
| Total Shareholders Funds | 282.43 | 262.63 | 222.55 | 203.22 | 154.46 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 25.34 | 0.74 | 2.07 | 3.44 | 6.13 | |
| Deferred Tax Liabilities [Net] | 2.48 | 2.19 | 1.37 | 1.91 | 2.38 | |
| Other Long Term Liabilities | 0.17 | 0.15 | 0.09 | 0.17 | 0.20 | |
| Long Term Provisions | 4.00 | 3.23 | 2.70 | 2.55 | 2.46 | |
| Total Non-Current Liabilities | 31.99 | 6.32 | 6.24 | 8.06 | 11.16 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 47.82 | 31.70 | 28.41 | 23.43 | 4.83 | |
| Trade Payables | 57.52 | 49.39 | 24.59 | 37.16 | 29.53 | |
| Other Current Liabilities | 12.15 | 4.70 | 4.61 | 4.47 | 7.15 | |
| Short Term Provisions | 1.48 | 0.81 | 0.69 | 0.59 | 0.63 | |
| Total Current Liabilities | 118.97 | 86.59 | 58.29 | 65.65 | 42.14 | |
| Total Capital And Liabilities | 433.39 | 355.54 | 287.08 | 276.93 | 207.77 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 142.12 | 85.30 | 87.59 | 88.31 | 63.62 | |
| Intangible Assets | 0.40 | 0.12 | 0.17 | 0.30 | 0.50 | |
| Capital Work-In-Progress | 49.73 | 45.52 | 26.31 | 6.43 | 12.35 | |
| Fixed Assets | 192.24 | 130.94 | 114.07 | 95.05 | 76.48 | |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 5.62 | 11.78 | 10.20 | 8.23 | 6.76 | |
| Total Non-Current Assets | 198.01 | 142.87 | 124.42 | 103.44 | 83.24 | |
| CURRENT ASSETS | ||||||
| Current Investments | 59.66 | 53.59 | 39.46 | 28.72 | 29.07 | |
| Inventories | 51.27 | 43.30 | 26.99 | 56.01 | 37.85 | |
| Trade Receivables | 81.55 | 89.62 | 65.87 | 63.98 | 37.56 | |
| Cash And Cash Equivalents | 5.86 | 1.72 | 13.04 | 0.83 | 4.78 | |
| Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OtherCurrentAssets | 37.03 | 24.43 | 17.29 | 23.96 | 15.27 | |
| Total Current Assets | 235.38 | 212.67 | 162.66 | 173.49 | 124.53 | |
| Total Assets | 433.39 | 355.54 | 287.08 | 276.93 | 207.77 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 13.47 | 19.86 | 14.11 | 14.83 | 7.86 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 59.66 | 53.59 | 39.46 | 28.72 | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 29.07 |
05.02.2026
NGL Fine Chem Consolidated December 2025 Net Sales at Rs 127.51 crore, up 43.11% Y-o-Y
04.02.2026
NGL Fine Chem Standalone December 2025 Net Sales at Rs 126.33 crore, up 45.49% Y-o-Y
26.11.2025
NGL Fine Chem Consolidated September 2025 Net Sales at Rs 120.26 crore, up 28.64% Y-o-Y
13.11.2025
NGL Fine Chem Standalone September 2025 Net Sales at Rs 116.84 crore, up 27.82% Y-o-Y
05.02.2026
NGL Fine Chem Consolidated December 2025 Net Sales at Rs 127.51 crore, up 43.11% Y-o-Y
04.02.2026
NGL Fine Chem Standalone December 2025 Net Sales at Rs 126.33 crore, up 45.49% Y-o-Y
26.11.2025
NGL Fine Chem Consolidated September 2025 Net Sales at Rs 120.26 crore, up 28.64% Y-o-Y
13.11.2025
NGL Fine Chem Standalone September 2025 Net Sales at Rs 116.84 crore, up 27.82% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth